(PM) Philip Morris International - Ratings and Ratios
Cigarettes, SmokeFree Products, Oral Nicotine, Lighters, Wellness Products
PM EPS (Earnings per Share)
PM Revenue
Description: PM Philip Morris International
Philip Morris International Inc. is a leading tobacco company that has diversified its product portfolio to include smoke-free alternatives, such as heat-not-burn, vapor, and oral nicotine products under the IQOS and ZYN brands. The companys product range also includes consumer accessories and wellness and healthcare products, positioning it for growth in a declining traditional tobacco market.
From a financial perspective, Philip Morris International Inc. has a market capitalization of approximately $278 billion, indicating its significant size and market presence. The companys price-to-earnings ratio is around 28, suggesting that investors are willing to pay a premium for its shares, possibly due to its diversified product portfolio and growth prospects. Additionally, the forward P/E ratio is lower, indicating expected earnings growth.
Key performance indicators (KPIs) that can be used to evaluate Philip Morris International Inc.s performance include revenue growth, operating margin, and return on equity (ROE). Although the provided ROE is negative, this is likely due to one-time or extraordinary items, as the companys overall financial health appears stable. Other relevant KPIs include the companys dividend yield and payout ratio, which are important for income investors. Philip Morris International Inc. has a history of paying consistent dividends, making it an attractive option for yield-seeking investors.
To further analyze Philip Morris International Inc.s prospects, it is essential to monitor its smoke-free product sales growth, particularly for IQOS and ZYN, as well as its operating margin expansion. The companys ability to navigate regulatory challenges and declining traditional tobacco demand will also be crucial in determining its long-term success. By tracking these KPIs and staying informed about industry trends, investors can make more informed decisions about Philip Morris International Inc.s potential.
PM Stock Overview
| Market Cap in USD | 258,565m |
| Sub-Industry | Tobacco |
| IPO / Inception | 2008-03-17 |
PM Stock Ratings
| Growth Rating | 92.8% |
| Fundamental | 73.1% |
| Dividend Rating | 68.8% |
| Return 12m vs S&P 500 | 15.9% |
| Analyst Rating | 4.06 of 5 |
PM Dividends
| Dividend Yield 12m | 3.40% |
| Yield on Cost 5y | 8.49% |
| Annual Growth 5y | 2.26% |
| Payout Consistency | 99.1% |
| Payout Ratio | 76.5% |
PM Growth Ratios
| Growth Correlation 3m | -68.8% |
| Growth Correlation 12m | 87.1% |
| Growth Correlation 5y | 89.1% |
| CAGR 5y | 26.53% |
| CAGR/Max DD 3y | 1.89 |
| CAGR/Mean DD 3y | 5.49 |
| Sharpe Ratio 12m | 2.14 |
| Alpha | 15.25 |
| Beta | 0.980 |
| Volatility | 22.16% |
| Current Volume | 3691.2k |
| Average Volume 20d | 4800.3k |
| Stop Loss | 160.8 (-3.2%) |
| Signal | -0.11 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (8.22b TTM) > 0 and > 6% of Revenue (6% = 2.34b TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA -2.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -12.26% (prev -3.81%; Δ -8.46pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 10.41b > Net Income 8.22b (YES >=105%, WARN >=100%) |
| Net Debt (47.29b) to EBITDA (12.71b) ratio: 3.72 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.56b) change vs 12m ago 0.13% (target <= -2.0% for YES) |
| Gross Margin 65.78% (prev 64.00%; Δ 1.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 58.09% (prev 55.41%; Δ 2.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.00 (EBITDA TTM 12.71b / Interest Expense TTM 1.88b) >= 6 (WARN >= 3) |
Altman Z'' 2.59
| (A) -0.07 = (Total Current Assets 23.36b - Total Current Liabilities 28.15b) / Total Assets 68.51b |
| (B) 0.50 = Retained Earnings (Balance) 34.38b / Total Assets 68.51b |
| (C) 0.17 = EBIT TTM 11.26b / Avg Total Assets 67.14b |
| (D) 0.27 = Book Value of Equity 21.22b / Total Liabilities 78.52b |
| Total Rating: 2.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.12
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 2.94% = 1.47 |
| 3. FCF Margin 23.05% = 5.76 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 4.05 = -2.50 |
| 6. ROIC - WACC 15.80% = 12.50 |
| 7. RoE data missing |
| 8. Rev. Trend 89.15% = 4.46 |
| 9. Rev. CAGR 8.84% = 1.11 |
| 10. EPS Trend -7.04% = -0.18 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of PM shares?
Over the past week, the price has changed by +2.08%, over one month by +0.51%, over three months by -8.69% and over the past year by +37.04%.
Is Philip Morris International a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PM is around 182.99 USD . This means that PM is currently undervalued and has a potential upside of +10.16% (Margin of Safety).
Is PM a buy, sell or hold?
- Strong Buy: 7
- Buy: 5
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the PM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 190.2 | 14.5% |
| Analysts Target Price | 190.2 | 14.5% |
| ValueRay Target Price | 203.3 | 22.4% |
Last update: 2025-09-15 04:42
PM Fundamental Data Overview
CCE Cash And Equivalents = 4.14b USD (last quarter)
P/E Trailing = 24.5725
P/E Forward = 19.802
P/S = 6.62
P/EG = 1.0651
Beta = 0.51
Revenue TTM = 39.01b USD
EBIT TTM = 11.26b USD
EBITDA TTM = 12.71b USD
Long Term Debt = 42.43b USD (from longTermDebt, last quarter)
Short Term Debt = 9.03b USD (from shortTermDebt, last quarter)
Debt = 51.46b USD (Calculated: Short Term 9.03b + Long Term 42.43b)
Net Debt = 47.29b USD (from netDebt column, last quarter)
Enterprise Value = 305.89b USD (258.57b + Debt 51.46b - CCE 4.14b)
Interest Coverage Ratio = 6.00 (Ebit TTM 11.26b / Interest Expense TTM 1.88b)
FCF Yield = 2.94% (FCF TTM 8.99b / Enterprise Value 305.89b)
FCF Margin = 23.05% (FCF TTM 8.99b / Revenue TTM 39.01b)
Net Margin = 21.06% (Net Income TTM 8.22b / Revenue TTM 39.01b)
Gross Margin = 65.78% ((Revenue TTM 39.01b - Cost of Revenue TTM 13.35b) / Revenue TTM)
Tobins Q-Ratio = 14.41 (Enterprise Value 305.89b / Book Value Of Equity 21.22b)
Interest Expense / Debt = 0.54% (Interest Expense 277.0m / Debt 51.46b)
Taxrate = 19.51% (2.38b / 12.20b)
NOPAT = 9.06b (EBIT 11.26b * (1 - 19.51%))
Current Ratio = 0.83 (Total Current Assets 23.36b / Total Current Liabilities 28.15b)
Debt / EBITDA = 4.05 (Net Debt 47.29b / EBITDA 12.71b)
Debt / FCF = 5.72 (Debt 51.46b / FCF TTM 8.99b)
Total Stockholder Equity = -11.08b (last 4 quarters mean)
RoA = 11.99% (Net Income 8.22b, Total Assets 68.51b )
RoE = unknown (Net Income TTM 8.22b / Total Stockholder Equity -11.08b)
RoCE = 35.91% (Ebit 11.26b / (Equity -11.08b + L.T.Debt 42.43b))
RoIC = 23.90% (NOPAT 9.06b / Invested Capital 37.91b)
WACC = 8.10% (E(258.57b)/V(310.03b) * Re(9.63%)) + (D(51.46b)/V(310.03b) * Rd(0.54%) * (1-Tc(0.20)))
Shares Correlation 3-Years: 92.93 | Cagr: 0.04%
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 72.10% ; FCFE base≈9.44b ; Y1≈9.13b ; Y5≈9.06b
Fair Price DCF = 79.16 (DCF Value 123.21b / Shares Outstanding 1.56b; 5y FCF grow -4.52% → 3.0% )
Revenue Correlation: 89.15 | Revenue CAGR: 8.84%
Rev Growth-of-Growth: -3.48
EPS Correlation: -7.04 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -14.15
Additional Sources for PM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle